We currently do not have sufficient information about the CEO.
Key information
Jonathan Cohen
Chief executive officer
US$325.5k
Total compensation
CEO salary percentage
76.81%
CEO tenure
26yrs
CEO ownership
12.9%
Management average tenure
6.3yrs
Board average tenure
10.1yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Jonathan Cohen's remuneration changed compared to 20/20 Biolabs's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2026
n/a
n/a
-US$5m
Dec 31 2025
US$325k
US$250k
-US$4m
Sep 30 2025
n/a
n/a
-US$3m
Jun 30 2025
n/a
n/a
-US$4m
Mar 31 2025
n/a
n/a
-US$5m
Dec 31 2024
US$796k
US$250k
-US$6m
Sep 30 2024
n/a
n/a
-US$6m
Jun 30 2024
n/a
n/a
-US$5m
Mar 31 2024
n/a
n/a
-US$6m
Dec 31 2023
US$976k
US$250k
-US$6m
Sep 30 2023
n/a
n/a
-US$6m
Jun 30 2023
n/a
n/a
-US$5m
Mar 31 2023
n/a
n/a
-US$2m
Dec 31 2022
n/a
n/a
US$2m
Sep 30 2022
n/a
n/a
US$4m
Jun 30 2022
n/a
n/a
US$6m
Mar 31 2022
n/a
n/a
US$4m
Dec 31 2021
n/a
n/a
US$2m
Compensation vs Market: Jonathan's total compensation ($USD325.50K) is below average for companies of similar size in the US market ($USD650.53K).
Compensation vs Earnings: Jonathan's compensation has been consistent with company performance over the past year.
CEO
Jonathan Cohen (62 yo)
26yrs
Tenure
US$325,499
Compensation
Mr. Jonathan Cohen serves as the Chief Executive Officer, President and Director at 20/20 Biolabs, Inc. since August 2000. Prior to starting 20/20, Mr. Cohen was patent and general counsel for two publical...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Jonathan Cohen
Founder
26yrs
US$325.50k
12.88% $ 818.1k
Jiming Zhou
Chief Operating Officer
6yrs
US$225.65k
0% $ 0
Michael Lebowitz
Chief Scientific Officer
6.6yrs
US$151.60k
0% $ 0
Alan Bergman
Chief Financial Officer
less than a year
no data
no data
David Lees
Director of Sales
3.6yrs
no data
no data
Ronald Baker
Chief Business Officer
6.8yrs
no data
0% $ 0
Marc Gordon
Controller
no data
no data
no data
6.3yrs
Average Tenure
58yo
Average Age
Experienced Management: AIDX's management team is seasoned and experienced (6.3 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Jonathan Cohen
Founder
26yrs
US$325.50k
12.88% $ 818.1k
Richard Cohen
Independent Director
10.1yrs
US$17.50k
0.063% $ 4.0k
John Rollins
Independent Director
8.8yrs
US$17.50k
0.25% $ 15.7k
John Compton
Independent Chairman
10.1yrs
US$20.00k
0.17% $ 10.9k
Michael Ross
Independent Director
10.1yrs
US$17.50k
0.00029% $ 18.4
Prasanth Reddy
Independent Director
2.8yrs
US$15.00k
0% $ 0
10.1yrs
Average Tenure
75.5yo
Average Age
Experienced Board: AIDX's board of directors are seasoned and experienced ( 10.1 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/08/14 13:16
End of Day Share Price
2026/08/14 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
20/20 Biolabs, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.